# BriaCell Therapeutics Corp.: Form 8-K, filed Aug 23, 2024

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 8-K
- Filed: 2024-08-23
- Accepted by EDGAR: Aug 23, 2024, 17:00 ET
- Period: 2024-08-22
- Accession: 0001493152-24-033753
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224033753/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315224033753/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315224033753/form8-k.htm

Filed Aug 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-033753. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.